2832-9023

Cochrane Evidence Synthesis and Methods

Wiley (John Wiley & Sons)

View prefix report (10.1002)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 83 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact83 DOIs
2

Attach ORCID iDs across 73 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact73 DOIs
3

Deposit reference lists for 69 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact69 DOIs

DOIs for this ISSN

Showing the top 5 of 166 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Responsible Integration of Artificial Intelligence in Rapid… (10.1002/cesm.70063)
Abstract
22.58 7
2 Cluster‐randomized controlled trials: A tutorial (10.1002/cesm.12024)
Abstract
21.13 6
3 Intention‐to‐treat analyses and missing outcome data: A tuto… (10.1002/cesm.12075)
Abstract
15.05 3
4 Equity in evidence synthesis: You can't play on broken strin… (10.1002/cesm.12091)
Abstract
15.05 3
5 Retiring the Term “Weighted Mean Difference” in Contemporary… (10.1002/cesm.70051)
Abstract
15.05 3
6 Split Body Trials in Systematic Reviews and Meta‐Analyses: A… (10.1002/cesm.70052)
Abstract ORCID
15.05 1
7 Launching “methods and statistics tutorials”: A collection o… (10.1002/cesm.12017)
Abstract
11.93 2
8 New directions beyond the boundaries of evidence synthesis (10.1002/cesm.12005)
Abstract
7.53 1
9 Measuring dichotomous outcomes using risk ratios, odds ratio… (10.1002/cesm.12022)
Abstract
7.53 1
10 Introducing a Series of Reviews Assessing Engagement in Evid… (10.1002/cesm.70057)
Abstract
7.53 1
11 Issue Information (10.1002/cesm.12)
Abstract References ORCID
0.00 0
12 Effect of pharmacological interventions for the treatment of… (10.1002/cesm.12001)
0.00 2
13 Quick prioritization of Cochrane reviews on benign condition… (10.1002/cesm.12002)
0.00 0
14 Issue Information (10.1002/cesm.12003)
Abstract References ORCID
0.00 0
15 Criteria adherence and citation impact of urologic Cochrane… (10.1002/cesm.12004)
0.00 0
16 How to develop rapid reviews of diagnostic tests according t… (10.1002/cesm.12006)
0.00 1
17 Issue Information (10.1002/cesm.12007)
Abstract References ORCID
0.00 0
18 Systematic reviewers' perspectives on sharing review data, a… (10.1002/cesm.12008)
0.00 9
19 Systematic reviewers' perspectives on replication of systema… (10.1002/cesm.12009)
0.00 8
20 A context‐specific conceptual framework of evidence synthesi… (10.1002/cesm.12010)
0.00 0
21 What did the scientific literature learn from internal compa… (10.1002/cesm.12011)
0.00 8
22 The equity group: Supporting Cochrane's social responsibilit… (10.1002/cesm.12012)
0.00 6
23 Issue Information (10.1002/cesm.12013)
Abstract References ORCID
0.00 0
24 Identifying important questions for Cochrane systematic revi… (10.1002/cesm.12014)
0.00 0
25 The impact of blinding on trial results: A systematic review… (10.1002/cesm.12015)
0.00 28
26 Issue Information (10.1002/cesm.12016)
Abstract References ORCID
0.00 0
27 Empowering workplace allies for lesbian, gay, bisexual, and… (10.1002/cesm.12018)
0.00 9
28 Should CINAHL be used as one of the main databases for evide… (10.1002/cesm.12019)
0.00 4
29 Issue Information (10.1002/cesm.12020)
Abstract References ORCID
0.00 0
30 Machine learning for accelerating screening in evidence revi… (10.1002/cesm.12021)
0.00 13
31 What tool do undergraduate pharmacy students prefer when gra… (10.1002/cesm.12023)
0.00 4
32 Issue Information (10.1002/cesm.12025)
Abstract References ORCID
0.00 0
33 Surgical excision methods for skin cancer involving the nail… (10.1002/cesm.12026)
0.00 1
34 Issue Information (10.1002/cesm.12027)
Abstract References ORCID
0.00 0
35 Responsibilities for receiving and using individual particip… (10.1002/cesm.12028)
0.00 5
36 Issue Information (10.1002/cesm.12029)
Abstract References ORCID
0.00 0
37 Effectiveness of SARS‐CoV‐2 testing strategies: A scoping re… (10.1002/cesm.12030)
0.00 3
38 Ten tips for successful assessment of risk of bias in random… (10.1002/cesm.12031)
0.00 20
39 Stakeholder involvement in a Cochrane review of physical reh… (10.1002/cesm.12032)
0.00 9
40 Multiarm studies and how to handle them in a meta‐analysis:… (10.1002/cesm.12033)
0.00 42
41 The international HTA database returned incomplete search re… (10.1002/cesm.12034)
0.00 0
42 Issue Information (10.1002/cesm.12035)
Abstract References ORCID
0.00 0
43 Development of the InSynQ checklist: A tool for planning and… (10.1002/cesm.12036)
0.00 4
44 Trustworthiness assessment as an inclusion criterion for sys… (10.1002/cesm.12037)
0.00 29
45 Mechanical ventilation core outcome set uptake in Cochrane s… (10.1002/cesm.12038)
0.00 0
46 Menu labeling and portion size control to improve the out‐of… (10.1002/cesm.12039)
0.00 0
47 Issue Information (10.1002/cesm.12040)
Abstract References ORCID
0.00 0
48 The use of a large language model to create plain language s… (10.1002/cesm.12041)
0.00 15
49 Quality of randomized controlled trials and systematic revie… (10.1002/cesm.12042)
0.00 2
50 Issue Information (10.1002/cesm.12043)
Abstract References ORCID
0.00 0